Related by context. All words. (Click for frequent words.) 69 blood Phe levels 68 serum uric acid 68 hemoglobin A1c HbA1c 66 serum LDL cholesterol 66 serum phosphate 66 Hb A1C 66 sUA 66 PASI scores 66 serum urate 65 serum phosphate levels 65 glycosylated hemoglobin levels 65 fasting plasma glucose FPG 64 glycated hemoglobin HbA1c 64 serum phosphorus 64 hyperphenylalaninemia HPA due 63 glycated hemoglobin levels 63 serum PTH 63 sUA levels 63 glycosylated hemoglobin HbA1c 63 HbA 1c 63 serum glucose 63 blood phenylalanine Phe 63 blood glucose concentrations 63 serum testosterone 63 HbA1C 63 HOMA IR 63 hsCRP levels 63 urinary N telopeptide 63 #.#mmHg 63 serum cortisol 63 HbA1C levels 62 hemoglobin concentrations 62 baseline serum creatinine 62 apolipoprotein B 62 corticosteroid dose 62 blood Phe 62 serum calcium levels 62 iPTH 62 #.#/#.# mmHg [001] 62 glomerular filtration 62 UACR 62 undetectable viral 62 HbA 1C 62 urinary albumin 62 baseline HbA1c 62 hemoglobin A1c levels 62 serum urate levels 62 serum insulin 62 Fasting plasma glucose 62 urinary albumin excretion 62 serum sodium 61 complete cytogenetic response 61 paraprotein 61 HbA 1c levels 61 aspartate aminotransferase AST 61 alanine aminotransferase ALT 61 elevated creatinine 61 plasma triglycerides 61 serum potassium 61 A1c levels 61 fasting insulin 61 dietary sodium 61 intact parathyroid hormone 61 #.#mmol L [001] 61 Cmax 61 triglyceride concentrations 61 serum lipid levels 61 serum bilirubin 61 ULORIC 61 urinary oxalate 61 Serum creatinine 61 plasma folate 60 statin monotherapy 60 atherogenic dyslipidemia 60 serum calcium 60 homocysteine concentrations 60 severe exacerbations 60 serum vitamin D 60 BENICAR HCT 60 dose Iluvien 60 calculated creatinine clearance 60 fasting plasma glucose 60 fructosamine 60 alanine aminotransferase 60 atorvastatin #mg 60 morphometric vertebral fractures 60 K DOQI 60 serum cholesterol 60 urine albumin 60 plasma cortisol 60 Fasting blood glucose 60 #.#mg/dL 60 postprandial blood glucose 60 serum concentrations 60 adenoma recurrence 60 serum triglyceride levels 59 serum triglycerides 59 serum folate 59 elevated uric acid 59 albumin excretion 59 glycosylated hemoglobin 59 μmol L 59 serum folate concentrations 59 fasting glucose levels 59 #mmHg [001] 59 moderate renal impairment 59 neutrophil counts 59 serum IGF 59 plasma leptin 59 AST ALT 59 lactate dehydrogenase LDH 59 LDL Cholesterol 59 serum phosphorous 59 glycemia 59 nonfasting triglycerides 59 serum retinol 59 lanthanum carbonate 59 umol L 59 plasma HCV RNA 59 μmol l 59 mucosal healing 59 draining enterocutaneous 59 irbesartan 59 #mg/day [002] 59 serum ALT 59 NPH insulin 59 fasting triglyceride levels 59 serum PSA 59 serum magnesium 59 peak VO2 59 lowering blood glucose 59 transaminases 59 oxycodone CR 59 elevated homocysteine 59 hemoglobin A1C 59 platelet inhibition 59 HBeAg seroconversion 59 diastolic blood pressures 58 N telopeptide 58 plasma homocysteine levels 58 LDL triglycerides 58 clinically meaningful reductions 58 glycated hemoglobin 58 transaminase levels 58 thyrotropin 58 HbA1c levels 58 metformin sulphonylurea 58 elevated serum creatinine 58 symptomatic VTE 58 hemoglobin concentration 58 lispro 58 annualized relapse 58 folate concentrations 58 serum uric acid sUA 58 calcium intakes 58 serum phosphorus levels 58 rimonabant #mg 58 plasma homocysteine 58 Crohn Disease Activity 58 anemia hemoglobin 58 serum homocysteine 58 EDARBI 58 LDL C 58 mg BID dose 58 lumbar spine BMD 58 choline intake 58 mmol l 58 NATRECOR R 58 fasting plasma 58 fasting blood glucose 58 plasma glucose levels 58 fosamprenavir 58 ACR# response 58 azilsartan medoxomil 58 apo B 58 #mmHg [002] 58 zonisamide SR 58 mL/min/#.# m 2 58 dietary folate 58 Platelet counts 58 hemoglobin Hb 58 elevated ALT 58 lipid lowering agents 58 elevated troponin 58 serum BDNF 58 severe periodontitis 58 #OHD levels 58 nonfasting triglyceride levels 58 infarct size 58 salivary flow 58 cerebral oxygen saturation 57 plasma urate 57 isoflavone intake 57 salmeterol fluticasone 57 transferrin saturation 57 insulin detemir 57 #mg dose [002] 57 #mg/day [001] 57 #mg/dL [002] 57 Ishak fibrosis score 57 nmol l 57 platelet reactivity 57 hip BMD 57 clinically meaningful improvement 57 mmHg diastolic 57 8 OHdG 57 aspartate aminotransferase 57 nicardipine 57 #mg/dL [001] 57 serum lipids 57 -#.# mg dL [002] 57 triacylglycerol concentrations 57 gastric pH 57 dietary calcium intake 57 urinary calcium 57 Serum calcium 57 PSA nadir 57 dapagliflozin plus 57 total cholesterol LDL 57 serum testosterone levels 57 serum leptin 57 quetiapine XR 57 leukocyte count 57 specific antigen PSA 57 serum clusterin levels 57 cinacalcet 57 steroid dexamethasone 57 primary hypercholesterolemia 57 elevated LDL cholesterol 57 QTcF 57 serum lipid 57 left ventricular diastolic 57 creatinine clearance 57 Index CDAI 57 pulmonary exacerbations 57 lipid parameters 57 CCyR 57 binary restenosis 57 Hb A1c 57 SGPT 57 hs CRP 57 periprocedural 57 hemoglobin A1C HbA1C 57 pCR 57 serum ferritin 57 postoperative mortality 57 #.#mmol l [002] 57 dalteparin 57 NOAEL 57 achieved ACR# 57 mm Hg diastolic 57 1c HbA 1c 57 #mg dose [001] 57 definite stent thrombosis 57 antioxidant supplementation 57 HbA1c 57 LEXIVA r 57 atheroma volume 57 vitamin D sufficiency 57 benazepril 57 Adequate vitamin D 57 circulating lymphocytes 56 transaminase elevations 56 SERCA2a 56 serum HBV DNA 56 CPAP adherence 56 polyp recurrence 56 postprandial glycemia 56 plasma triglyceride levels 56 tHcy 56 CLA supplementation 56 fluticasone salmeterol 56 CK MB 56 malondialdehyde MDA 56 dose ritonavir 56 atherogenic lipids 56 insulin glulisine 56 secondary efficacy endpoint 56 systolic blood pressures 56 mineral density 56 lymphocyte counts 56 μg L 56 relapsed MM 56 bioavailable testosterone 56 dose clopidogrel 56 elevated LDH 56 dosing frequency 56 HDL triglycerides 56 hydroxyvitamin D levels 56 A1C levels 56 normal ULN 56 #/#mmHg 56 NIHSS 56 cardiovascular morbidity 56 OGTT 56 RBC transfusions 56 thyrotropin levels 56 hepatic fat 56 cholesterol LDL C 56 non fasting triglycerides 56 coronary stenosis 56 serum selenium 56 carotid artery intima media 56 colesevelam HCl 56 undetectable HBV DNA 56 Skin sterol 56 MAS XR 56 glycemic variability 56 oral antidiabetic medication 56 aminotransferase ALT 56 BENICAR 56 mEq L 56 magnesium intake 56 tapentadol ER 56 urinary BPA 56 symptomatic intracranial hemorrhage 56 systemic corticosteroid 56 metformin sulfonylurea 56 cystatin C 56 insulin glargine 56 -#.# log# 56 plasma renin activity 56 plasma renin 56 glucose insulin 56 Secondary efficacy endpoints 56 baseline A1C 56 chronic periodontitis 56 systolic BP 56 thromboxane A2 56 EDSS scores 56 XIENCE V PROMUS Stent 56 paricalcitol 56 dose colchicine 56 glomerular filtration rate 56 HBV DNA levels 56 elevated triglycerides 56 intima media thickness 56 serum CRP 56 Lantus ® 56 nondiabetic patients 56 coadministration 56 Psoriasis Area 56 certolizumab 56 mean baseline HbA1c 56 rectovaginal fistulas 56 serum creatinine levels 56 ALT AST 56 β blockers 56 density lipoprotein HDL cholesterol 56 neurodevelopmental outcomes 56 Zemplar Capsules 56 #mg doses [002] 56 ng dL 56 lumbar spine bone 56 Calcium intake 56 adjunctive placebo 55 ADCS CGIC 55 LDL cholesterol HDL cholesterol 55 exhaled NO 55 bad cholesterol LDL 55 bezafibrate 55 biphasic insulin aspart 55 serum albumin 55 SpO 2 55 LDL HDL ratio 55 probiotic supplementation 55 nephrotoxicity 55 acromegalic patients 55 #ug [001] 55 urinary cortisol 55 LDL cholesterol lowering 55 metformin monotherapy 55 lipid lowering therapy 55 #.#mmol L [002] 55 serum parathyroid hormone 55 fluvastatin 55 sargramostim 55 nonvertebral fractures 55 LDL cholesterol concentrations 55 poor metabolizers 55 6mg 55 pulmonary capillary wedge 55 candesartan cilexetil 55 serum sodium levels 55 KDOQI 55 ruboxistaurin 55 dose statin therapy 55 ALT elevations 55 angiographic outcomes 55 CDAI score 55 nonvertebral fracture 55 serum aminotransferase levels 55 nmol L 55 alanine transaminase 55 lowest tertile 55 rizatriptan 55 NCEP ATP III 55 ginkgo biloba extract 55 urinary citrate 55 Hb levels 55 density lipoprotein cholesterol HDL 55 dose atorvastatin 55 isoprostane 55 8mg/kg 55 PASI score 55 Creatinine 55 troponin T 55 trans fat intake 55 PRADAXA #mg 55 virologic response 55 lipid elevations 55 thiazide diuretics 55 Insulin sensitivity 55 MADRS score 55 CrCl 55 IR Cysteamine 55 cardio respiratory fitness 55 fasting triglycerides 55 Hemoglobin A1c 55 albumin excretion rate 55 TC HDL 55 autoantibody levels 55 fetuin 55 highest tertile 55 Scale EDSS score 55 HDL Cholesterol 55 serum triglyceride 55 mg/m2 dose 55 ghrelin concentrations 55 mg dL 55 estimated glomerular filtration 55 Fasting glucose 55 abacavir lamivudine 55 dyslipidaemia 55 calcium phosphorus 55 alanine transaminase ALT 55 rosuvastatin #mg 55 nocturnal hypoglycaemia 55 attain statistical significance 55 Secondary endpoints include 55 thyroid stimulating hormone 55 aminotransferases 55 Durezol 55 methylmalonic acid 55 Montgomery Åsberg Depression 55 systolic diastolic blood 55 SGOT 55 myeloperoxidase 55 postprandial glucose 55 = #.#-#.# 55 serum TSH 55 salmeterol fluticasone propionate 55 RBP4 levels 55 anginal pain 55 tapentadol IR 55 severe hepatic insufficiency 55 IRLS score 55 creatine kinase 55 HMG CoA reductase inhibitor 55 PREZISTA r 55 natriuresis 55 serum estradiol 55 #μg [002] 55 inflammatory biomarkers 54 confidence intervals CIs 54 concomitant medications 54 creatinine ratio 54 urinary cadmium 54 Engerix B 54 abdominal adiposity 54 DAS# remission 54 ACR# responses 54 maximal doses 54 mIU L 54 Elitek 54 androgen depletion 54 c reactive protein 54 Triglyceride levels 54 CsA 54 MULTAQ 54 microbiologically evaluable 54 statistical significance p 54 Acetate Rectal Suppositories 54 nanograms milliliter 54 alfuzosin 54 endoscopic remission 54 hypercholesterolaemia 54 #mg dose [003] 54 tertiles 54 1mg dose 54 Non inferiority 54 colorectal adenoma 54 triglyceride concentration 54 hepatic glucose production 54 carotid stenosis 54 hemoglobin A1c 54 diastolic BP 54 oral hypoglycemic agents 54 QIDS SR 54 oocytes retrieved 54 LVEF 54 urate lowering therapy 54 evaluable subjects 54 serum prostate 54 oral antidiabetic drugs 54 beta blocker therapy 54 cardiac autonomic 54 maximally tolerated 54 prolactin levels 54 NNT = 54 CR nPR 54 flow mediated dilation 54 triacylglycerol 54 protein excretion 54 plasma glucose 54 pharmacokinetic PK profile 54 #OHD 54 elevated fasting glucose 54 treprostinil 54 salivary cortisol 54 antigen PSA levels 54 bone marrow reticulin 54 posaconazole 54 severe asthma exacerbations 54 tipranavir r 54 Phe restricted diet 54 NIHSS score 54 mmol 54 residual platelet reactivity 54 postprandial insulin 54 diastolic pressures 54 FeNO 54 x ULN 54 folate intake 54 overt nephropathy 54 mild renal insufficiency 54 symptomatic intracerebral hemorrhage 54 4mg/kg 54 Secondary endpoints included 54 nmol L. 54 obstructive CAD 54 severe renal impairment 54 mcg mL 54 #ng/ml 54 antiarrhythmic drug 54 maximal dose 54 triiodothyronine 54 APTIVUS R 54 antihypertensive therapy 54 triglycerides fatty acids 54 HDL C 54 elevated triglyceride levels 54 atherothrombotic events 54 exhaled nitric oxide 54 antioxidant intake 54 μg liter 54 urinary excretion 54 CD# upregulation 54 T2DM 54 GnRH agonist 54 serum HCV RNA 54 placebo dexamethasone 53 maximally tolerated dose 53 subclinical hypothyroidism 53 AEGR 53 indapamide 53 vasodilatation 53 apolipoprotein A1 53 KAPIDEX 53 tissue oxygenation 53 ApoB 53 testosterone supplementation 53 lipoprotein Lp 53 Toremifene 53 9mg 53 intra ocular pressure 53 sitosterol 53 CRESTOR #mg 53 LANTUS R 53 biochemical relapse 53 elevated CRP 53 CD4 + cell 53 Lp PLA 2 53 KOMBIGLYZE XR 53 Procoralan 53 hepatic function 53 pyridostigmine 53 0mg 53 plasma glucose concentrations 53 recurrent venous thromboembolism 53 mL/min/#.# m2 53 HUMIRA adalimumab 53 thromboembolic events 53 glargine 53 tamsulosin 53 Kaplan Meier analysis 53 timepoints 53 antihypertensive medications 53 cerebral oxygenation 53 CONCERTA 53 sodium excretion 53 ® lenalidomide 53 selenium intake 53 hypogonadal 53 MCyR 53 DAS# scores 53 Lipitor #mg 53 aldosterone antagonist 53 CVD mortality 53 ADCS ADL 53 adiponectin concentrations 53 Fibrates 53 CHD mortality 53 glycemic control 53 kaempferol 53 Calorie intake 53 plasma lipids 53 protease inhibitor PI 53 hypogonadal men 53 HIV HCV coinfected 53 ACE inhibitor ramipril 53 BMI percentiles 53 XEPLION R 53 flutamide 53 sulphonylurea 53 plasma lipid 53 hours postdose 53 ratio ICER 53 urate levels 53 exogenous insulin 53 mL kg 53 % Confidence Interval 53 INCB# [003] 53 PSADT 53 EDSS score 53 Ramipril 53 lymphocyte count 53 alkaline phosphatase 53 antidiabetic medication 53 fructose sweetened beverages 53 asymptomatic carotid stenosis 53 pg mL 53 LDL lowering 53 serum cotinine 53 subcutaneous insulin 53 gm dl 53 lispro alone 53 mm Hg systolic 53 tHcy concentrations 53 spirometric 53 unfractionated heparin UFH 53 eplerenone 53 apoB 53 inhaled iloprost 53 improves glycemic 53 Pioglitazone 53 tolvaptan 53 UPDRS scores 53 tertile 53 LDL cholesterol levels 53 CDI recurrence 53 weekly subcutaneous injections 53 cTnT levels 53 antibody titer 53 LDL HDL 53 per deciliter mg 53 A1C 53 Sitagliptin 53 fructose diet 53 Rasilez Tekturna 53 mmHg systolic 53 visceral adiposity 53 recurrent ischemia 53 serotonin synthesis 53 oral glucose tolerance 53 eosinophils echocardiogram serum troponin 53 fasting plasma insulin 53 lipid lowering medication 53 intraocular pressure IOP 53 dose pravastatin 53 vascular reactivity 53 ritonavir boosted 53 carotid IMT 53 #mg/dl 53 serum potassium levels 53 posttreatment 53 virological suppression 53 EQUETRO 53 low dose Iluvien 53 fraction LVEF 53 APTIVUS r 53 MMSE scores 53 mcg QD 53 Zometa hazard 53 mU L 53 arterial oxygen saturation 53 echocardiographic parameters 53 microg 53 OADs 53 Pred Forte 53 tirofiban 53 Apidra ® 53 β blocker 53 calcium supplementation 53 neurologic impairment 53 acarbose 52 statin simvastatin 52 TOVIAZ 52 CIMZIA TM 52 Stop Hypertension DASH diet 52 metabolic acidosis 52 D dimer 52 cardiac troponin T 52 ABCB1 52 hypertensives 52 MS relapses 52 revascularizations 52 NSTE ACS 52 pravastatin Pravachol 52 dietary sodium intake 52 antihypertensive medication 52 achieved statistical significance 52 liver transaminases 52 glycaemia 52 maintaining Hb 52 myocardial uptake 52 lipid levels 52 B7 H3 52 hsCRP 52 hydroxyvitamin D concentrations 52 elevated TSH 52 oral allopurinol 52 multivariable adjusted 52 antidiabetic medications 52 Hemoglobin A1c HbA1c 52 warfarin therapy 52 #μg [001] 52 EFFEXOR XR 52 plasma fibrinogen 52 triacylglycerols 52 -#.# mg dL [001] 52 glulisine 52 Glypromate 52 serum bicarbonate 52 lowers blood glucose 52 preintervention 52 arterial thromboembolic events 52 mIU ml 52 advanced adenoma 52 A1c 52 ertapenem 52 nondiabetic 52 vWF 52 NQO1 52 oral antidiabetic medications 52 SHPT 52 carotid plaque 52 MP4OX 52 International Normalized Ratio 52 angiotensin converting enzyme inhibitors 52 folic acid intake 52 NovoLog ® Mix 52 nanomoles per 52 recurrent VTE 52 idraparinux 52 Welchol 52 euthyroid 52 pioglitazone HCl 52 erythrocyte sedimentation rate 52 dopamine D2 receptor 52 ACR Pedi 52 tiotropium bromide 52 lactate dehydrogenase 52 macroalbuminuria 52 glimepiride 52 colorectal neoplasia 52 antidiabetic drugs 52 prednisone prednisolone 52 CI -#.# 52 Stop Hypertension diet 52 R0 resection 52 severe renal insufficiency 52 nitroprusside 52 oxycodone IR 52 epoetin alpha 52 nonsignificant difference 52 gallstone disease 52 creatinine levels 52 atazanavir ritonavir 52 FTE staffing 52 haemorrhagic stroke 52 systemic hypotension 52 dietary carbohydrate 52 -#.# ± [001] 52 AUC0 #hr 52 diameter stenosis 52 Hypoglycaemia 52 unfractionated heparin 52 malondialdehyde 52 μg mL 52 silymarin 52 advanced adenomas 52 oral antidiabetes 52 SCr 52 μg kg 52 recurrent UTI 52 carotid intima media 52 simvastatin #mg 52 angiotensin II receptor blocker 52 nonfatal myocardial infarction 52 isolated systolic hypertension 52 g dL 52 mmol L. 52 cortisol concentrations 52 uric acid levels 52 mcg BID 52 Expanded Disability Status 52 postmenopausal hormone 52 leukocyte counts 52 microalbumin 52 aminotransferase levels 52 NHANES III 52 systemic embolism 52 mg kg dose 52 adjunctive ABILIFY 52 hyperphosphatemia elevated serum phosphorous 52 CDAI 52 distal colon cancer 52 Tekamlo 52 preoperatively 52 impaired endothelial 52 subclinical atherosclerosis 52 #mm Hg 52 metabolic parameters 52 LV dysfunction 52 #.#/#.# mm Hg [003] 52 procalcitonin 52 mixed hyperlipidemia 52 postoperative morbidity 52 Index CDAI score 52 hepatic enzymes 52 LDL oxidation 52 ATACAND 52 Betaferon R 52 ARCOXIA 52 carbohydrate absorption 52 REYATAZ r arm 52 Endothelial function 52 anti Xa 52 hydroxymethyl coenzyme 52 pramlintide 52 elevated LDL 52 blood glucose levels 52 basal bolus therapy 52 serum lactate 52 cardiovascular hospitalizations 52 tracer uptake 52 virologic suppression 52 T1DM 52 lopinavir r arm 52 neurodevelopmental outcome 52 intensive lipid lowering 52 detemir 52 nonfatal MI 52 NovoMix ® 52 FAMPYRA 52 loop diuretics 52 undetectable HCV RNA 52 strontium ranelate 52 cardiometabolic risk 52 hypercalciuria 52 gliclazide 52 p = .# [002] 52 systolic dysfunction 52 vitamin K1 52 oral prednisolone 51 acetaminophen codeine 51 amino acid homocysteine 51 partial thromboplastin 51 Lp PLA2 51 Caloric intake 51 ApoA1 51 microvascular complications 51 hemoglobin Hb levels 51 adrenal function 51 retinal thickness 51 #mg BID [003] 51 cirrhotic patients 51 Eligen R B# 51 impaired fasting glucose 51 hemoglobin hematocrit 51 plasma uric acid 51 chronic prostatitis chronic 51 6MWD 51 #.#g/day 51 μg dL 51 sustained virologic response 51 PREZISTA r arm 51 elevated hsCRP 51 metabolic syndrome MetS 51 lipid lowering drugs 51 aspirin clopidogrel 51 + PH# 51 ejection fractions 51 gestational hypertension 51 Homocysteine 51 ximelagatran 51 fasting glucose 51 sitagliptin 51 medication nonadherence 51 DULERA 51 APTIVUS 51 NATRECOR ® 51 REMINYL ® 51 serum GGT 51 neural tube birth defects 51 candesartan 51 Abbott Trilipix 51 hydroxy vitamin D 51 density lipoprotein cholesterol 51 creatine phosphokinase 51 A1Cs 51 adiponectin levels 51 IPSS 51 gout flares 51 proteinuria 51 plasma selenium 51 Glycemic 51 CIMZIA R 51 XIENCE V demonstrated 51 Tumor shrinkage 51 Arixtra ® 51 Atacand 51 rapid virological response 51 ivabradine 51 skeletal muscle mass 51 ALT elevation 51 Thiazolidinediones 51 CRP marker 51 Oxidized LDL 51 Baseline characteristics 51 ursodeoxycholic acid 51 urine NGAL 51 left ventricular systolic 51 renal impairment 51 moderate hepatic impairment 51 Lucentis monotherapy 51 muscle protein synthesis 51 onset diabetes mellitus 51 mg kg Hematide 51 pegylated IFN 51 International Prostate Symptom 51 PEDF 51 dietary nitrate 51 insulin degludec 51 TRILIPIX 51 p = NS 51 cardiorespiratory fitness 51 mg BID 51 Angiomax monotherapy 51 diastolic blood pressure 51 endometrial thickness 51 rescheduled elective surgeries 51 PROCTOCORT ® Suppository Hydrocortisone 51 experienced virologic failure 51 fat vegan diet 51 mg simvastatin 51 lomitapide 51 nonpregnant women 51 PLX STROKE targeting 51 infliximab monotherapy 51 Darapladib 51 μg dl 51 postprandial glucose levels 51 SHBG levels 51 diuretic chlorthalidone 51 thyroid hormone levels 51 peptide YY 51 psychosocial variables 51 mealtime insulin 51 Cotinine 51 .5 milligrams 51 LDL cholesterol LDL 51 mcg Albuferon 51 urinary protein 51 pravastatin therapy 51 Triglyceride 51 methotrexate monotherapy 51 plasma concentrations 51 apnea hypopnea index 51 allowance RDA 51 Pischon 51 inflammatory lesions 51 postintervention 51 hepatic fibrosis 51 fetal malformations 51 Viral load 51 tacrolimus ointment 51 eosinophil count